Trial Profile
A phase II study of Influenza A virus H7N9 vaccine in adults
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 03 Aug 2015
Price :
$35
*
At a glance
- Drugs Influenza A virus vaccine H7N9 (Primary)
- Indications Influenza A virus H7N9 subtype
- Focus Therapeutic Use
- 03 Aug 2015 New trial record
- 30 Jul 2015 According to a company media release, Novavax plans to initiate this study in the first quarter of 2016.